PBMCs from three CLL patient samples were treated with single agents or drug combinations for 30 min, followed by 5‐min stimulation with anti‐IgM to activate the B‐cell receptor (Fig. 2A,B). This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.